Has Big Pharma exposed society to undue risk in the covid era? In our 2nd episode on this issue, Tahir Amin (i-mak.org) takes us through the R & D ecosystem of pharmaceutical development. Is Big Pharma's role to develop life saving products or digest competition? Listeners will understand why this market is in urgent need of a major overhaul. As always, policy pathways are provided as a matter of courtesy. Show notes